Science Explorer Back to mapMap
Discussion
Company · Tampa · United States

Intezyne (United States)

Research works
17
▼ 100% vs 2018-21
Citations
180
10.8 per fractional work
Top-10% rate
7.4%
all institutions 10.0%
Open access
27%
world 40%
International
2%
world 18%

Not ranked overall: Intezyne (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Intezyne (United States) work in?

In all years, 43% of research at Intezyne (United States) is in Life Sciences, 36% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (43%), Medicine (22%), Materials Science (17%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 7 fractional works · 42.5% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 42.5% of its workMolecular Biology: 6 fractional works · 34.4% of its workCell Biology: 1 fractional works · 3.2% of its workBiotechnology: 0 fractional works · 3.0% of its workCancer Research: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 1.0% of its workPhysical Sciences: 6 fractional works · 35.9% of its workMaterials Science: 3 fractional works · 16.7% of its workBiomaterials: 3 fractional works · 15.4% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.4% of its workEngineering: 2 fractional works · 10.0% of its workBiomedical Engineering: 2 fractional works · 9.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workChemistry: 2 fractional works · 9.1% of its workOrganic Chemistry: 2 fractional works · 9.1% of its workHealth Sciences: 4 fractional works · 21.6% of its workMedicine: 4 fractional works · 21.6% of its workOncology: 2 fractional works · 12.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 6.1% of its workEpidemiology: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workRheumatology: 0 fractional works · 0.7% of its workALL ITS WORKIntezyne (UnitedStates)17fractional works, all years
Life Sciences43%Physical Sciences36%Health Sciences22%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology742.5%
    1. Materials Science316.7%
    2. Engineering210.0%
    3. Chemistry29.1%
    1. Medicine421.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Intezyne (United States)?

Ranked on the quality score, Suzanne J. Bakewell, Kevin Sill and Tomáš Vojkovský lead among researchers whose main affiliation is Intezyne (United States).

  1. 1 Suzanne J. Bakewell United States · #1,205,422 worldwide 851 citations · 45 works
  2. 2 Kevin Sill United States · #1,434,171 worldwide 2.2k citations · 50 works
  3. 3 Tomáš Vojkovský United States · #1,794,902 worldwide 818 citations · 25 works
  4. 4 Grégoire Cardoen United States · #2,807,415 worldwide 326 citations · 28 works
  5. 5 Adam Carie United States · #3,597,697 worldwide 557 citations · 50 works
All ranked researchers at Intezyne (United States)

What are the most cited papers from Intezyne (United States)?

The most cited paper from Intezyne (United States) is "Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort" (Howard A. Burris, Suzanne J. Bakewell, Johanna C. Bendell et al., 2016), with 157 citations. Next come "A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs" (53) and "Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor" (52).

Most cited papers
#PaperReleasedCitations
1 Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort Howard A. Burris, Suzanne J. Bakewell, Johanna C. Bendell et al. · ESMO Open Open access 2016 157
2 A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs Jonathan Rios‐Doria, Adam Carie, Tara Lee Costich et al. · Journal of Drug Delivery Open access Feb 2012 53
3 Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor Suzanne J. Bakewell, Daisy Flores Rangel, Dat P. Ha et al. · Oncotarget Open access 3 Jul 2018 52
4 Synthesis and Characterization of Micelle-Forming PEG-Poly(Amino Acid) Copolymers with Iron-Hydroxamate Cross-Linkable Blocks for Encapsulation and Release of Hydrophobic Drugs Kevin Sill, Bradford Sullivan, Adam Carie et al. · Biomacromolecules Open access 5 May 2017 48
5 Development of Melanoma-Targeted Polymer Micelles by Conjugation of a Melanocortin 1 Receptor (MC1R) Specific Ligand Natalie M. Barkey, Narges K. Tafreshi, Jatinder S. Josan et al. · Journal of Medicinal Chemistry Open access 19 Oct 2011 48
All 16 most cited papers, with filters and sorting

Which research topics does Intezyne (United States) publish most on?

By volume: Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics and Advanced biosensing and bioanalysis techniques.

  1. 1 Nanoparticle-Based Drug Delivery Biomaterials 3 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 1 works
  3. 3 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  4. 4 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  5. 5 Cancer therapeutics and mechanisms Molecular Biology 1 works
  6. 6 Click Chemistry and Applications Organic Chemistry 1 works
  7. 7 DNA and Nucleic Acid Chemistry Molecular Biology 1 works
  8. 8 Cancer Treatment and Pharmacology Oncology 1 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Drug Transport and Resistance Mechanisms Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.3%not open72.7%

World: 40% of research is openly available.

with international co-authors1.5%domestic only98.5%

World: 18% is written across borders.

How has Intezyne (United States)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tampa

All research institutions in Tampa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Intezyne (United States). Posts are plain text and can be reported.